These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1279928)

  • 1. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss.
    Probst R; Tschopp K; Lüdin E; Kellerhals B; Podvinec M; Pfaltz CR
    Acta Otolaryngol; 1992; 112(3):435-43. PubMed ID: 1279928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized double-blind study of therapy of sudden deafness: initial results].
    Desloovere C; Meyer-Breiting E; von Ilberg C
    HNO; 1988 Oct; 36(10):417-22. PubMed ID: 2466024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the time from the onset to the treatment a prognostic indicator for hearing recovery in idiopathic sudden sensorineural hearing loss?
    Uysal İÖ; Müderris T; Polat K; Yüce S; Gültürk S
    Kulak Burun Bogaz Ihtis Derg; 2015; 25(2):70-6. PubMed ID: 25935056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy in sensorineural hearing loss in childhood].
    Nickisch A; Heinemann M; Gross M
    Laryngol Rhinol Otol (Stuttg); 1987 Dec; 66(12):664-6. PubMed ID: 3431317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study.
    Kronenberg J; Almagor M; Bendet E; Kushnir D
    Laryngoscope; 1992 Jan; 102(1):65-8. PubMed ID: 1370568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo].
    Poser R; Hirche H
    HNO; 1992 Oct; 40(10):396-9. PubMed ID: 1385372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline versus Steroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss with Diabetes.
    Lan WC; Wang CY; Lin CD
    J Int Adv Otol; 2018 Aug; 14(2):176-180. PubMed ID: 30100538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study.
    Suckfuell M; Lisowska G; Domka W; Kabacinska A; Morawski K; Bodlaj R; Klimak P; Kostrica R; Meyer T
    Otol Neurotol; 2014 Sep; 35(8):1317-26. PubMed ID: 24979398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Course and prognosis in sudden deafness].
    Eichhorn T; Martin G
    HNO; 1984 Aug; 32(8):341-5. PubMed ID: 6207152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diatrizoate and dextran treatment of sudden sensorineural hearing loss.
    Redleaf MI; Bauer CA; Gantz BJ; Hoffman HT; McCabe BF
    Am J Otol; 1995 May; 16(3):295-303. PubMed ID: 8588622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study.
    Reisser CH; Weidauer H
    Acta Otolaryngol; 2001 Jul; 121(5):579-84. PubMed ID: 11583389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials.
    Plontke S; Löwenheim H; Preyer S; Leins P; Dietz K; Koitschev A; Zimmermann R; Zenner HP
    Acta Otolaryngol; 2005 Aug; 125(8):830-9. PubMed ID: 16158529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases.
    Liu SC; Kang BH; Lee JC; Lin YS; Huang KL; Liu DW; Su WF; Kao CH; Chu YH; Chen HC; Wang CH
    Clin Otolaryngol; 2011 Apr; 36(2):121-8. PubMed ID: 21414179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of hearing recovery according to frequency in patients with acute acoustic sensorineural hearing loss.
    Harada H; Ichikawa D; Imamura A
    Int Tinnitus J; 2008; 14(1):83-7. PubMed ID: 18616091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characterization of patients with idiopathic sudden sensorineural hearing loss].
    Brors D; Eickelmann AK; Gäckler A; Sudhoff H; Lautermann J; Dazert S; Kunstmann E
    Laryngorhinootologie; 2008 Jun; 87(6):400-5. PubMed ID: 18236360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the addition of hyperbaric oxygen therapy to conventional treatment modalities influence the outcome of soldiers with idiopathic sudden sensorineural hearing loss?
    Chi TH; Chiang MC; Chen RF; Yuan CH
    J R Army Med Corps; 2018 May; 164(2):69-71. PubMed ID: 29431146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial.
    Nosrati-Zarenoe R; Hultcrantz E
    Otol Neurotol; 2012 Jun; 33(4):523-31. PubMed ID: 22429944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.